B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Diazepam

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.

999 PubMed studies analyzed ยท 672 RCTs ยท Evidence Score: 66.9

Research Domains

Diazepam has been studied across 18 research domains including ๐Ÿง˜ Stress & Anxiety, ๐Ÿ˜ด Sleep, ๐Ÿ’Š Pain, โค๏ธ Cardiovascular, ๐ŸŒค๏ธ Mood & Depression. The primary research focus is ๐Ÿง˜ Stress & Anxiety with 30% of studies addressing this area.

Loading evidence profile...

This evidence profile for Diazepam is generated deterministically from 999 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.